Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018;39(2):239-246.
doi: 10.1080/08897077.2017.1389798. Epub 2018 May 16.

Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes

Affiliations
Comparative Study

Effect of a high dosage opioid prior authorization policy on prescription opioid use, misuse, and overdose outcomes

Daniel M Hartung et al. Subst Abus. 2018.

Abstract

Background: High dosage opioid use is a risk factor for opioid-related overdose commonly cited in guidelines, recommendations, and policies. In 2012, the Oregon Medicaid program developed a prior authorization policy for opioid prescriptions above 120 mg per day morphine equivalent dose (MED). This study aimed to evaluate the effects of that policy on utilization, prescribing patterns, and health outcomes.

Methods: Using administrative claims data from Oregon and a control state (Colorado) between 2011 and 2013, we used difference-in-differences analyses to examine changes in utilization, measures of high risk opioid use, and overdose after introduction of the policy. We also evaluated opioid utilization in a cohort of individuals who were high dosage opioid users before the policy.

Results: Following implementation of Oregon's high dosage policy, the monthly probability of an opioid fill over 120 mg MED declined significantly by 1.7 percentage points (95% confidence interval [CI]; -2.0% to -1.4%), whereas it increased significantly by 1.0 percentage points (95% CI 0.4% to 1.7%) for opioid fills < 61 mg MED. Fills of medications used to treat neuropathic pain also increased by 1.2 percentage points (95% CI 0.7% to 1.8%). The monthly probability of multiple pharmacy use declined by 0.1 percentage points (-0.2% to -0.0) following the prior authorization, but there were no significant changes in ED encounters or hospitalizations for opioid overdose. Among individuals who were using a high dosage opioid before the policy, there was a 20.3 percentage point (95% CI -15.3% to -25.3%) decline in estimated probability of having a high dosage fill after the policy.

Conclusions: Oregon's prior authorization policy was effective at reducing high dosage opioid prescriptions. While multiple pharmacy use also declined, we found no impact on opioid overdose were observed.

Keywords: Medicaid; Opioid; overdose; prior authorization.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest.

Figures

Figure 1.
Figure 1.
Opioid prescriptions filled per 100 enrolled individuals (total, >120 MED, 61–120 MED, and <61 MED) from January 2011 to December 2013 in Oregon and Colorado. Solid line indicates Oregon, and dashed line indicates Colorado; vertical lines indicate policy implementation period April 2012 to June 2012. MED = morphine equivalent dose per day. *P < 0.05.

References

    1. Centers for Disease Control and Prevention. Wide-ranging Online Data for Epidemiologic Research (WONDER). Atlanta, GA: Centers for Disease Control and Prevention; 2015.
    1. Miller M, Barber CW, Leatherman S, et al. Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy. JAMA Intern Med 2015;175:608–615. doi: 10.1001/jamainternmed.2014.8071. - DOI - PubMed
    1. Paulozzi LJ, Zhang K, Jones CM, Mack KA. Risk of adverse health outcomes with increasing duration and regularity of opioid therapy. J Am Board Fam Med. 2014;27:329–338. doi: 10.3122/jabfm.2014.03.130290. - DOI - PMC - PubMed
    1. King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990–2013: a systematic review. Am J Public Health. 2014;104: e32–e42. doi: 10.2105/AJPH.2014.301966. - DOI - PMC - PubMed
    1. Bohnert AS, Logan JE, Ganoczy D, Dowell D. A detailed exploration into the association of prescribed opioid dosage and overdose deaths among patients with chronic pain. Med Care. 2016;54:435–441. doi: 10.1097/MLR.0000000000000505. - DOI - PMC - PubMed

Publication types

Substances